Clinical Trial Update: Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir [NA]

View source ↗

Summary

A completed clinical trial comparing continuing Tenofovir disoproxil fumarate with Emtricitabine (or Lamivudine) plus Lopinavir versus switching to a regimen of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Emtricitabine (Emtricitabine)
• Lamivudine (lamivudine)
• Lopinavir (lopinavir)
• Raltegravir (raltegravir)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: National Center for Global Health and Medicine, Japan | Conditions: HIV Infections | NA | Status: COMPLETED